Successful treatment of rheumatoid arthritis is associated with a reduction in serum sE-selectin and thrombomodulin level

Clinical Rheumatology

Volumn 23, Issue 5, 2004, Pages 430-434

  Çobankara, Veli ^a   Özatli, Düzgün ^b   Kiraz, Sedat ^c   Öztürk, Mehmet Akif ^d   Ertenli, Ihsan ^c   Türk, Tufan ^a   Apras, Şule ^c   Haznedaroglu, Ibrahim C ^c   Çalgüneri, Meral ^c  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b SSK Etlik Hospital   (Turkey)

^c HACETTEPE UNIVERSITY   (Turkey)

^d GAZI UNIVERSITY   (Turkey)

Author keywords

E selectin; Methotrexate; Rheumatoid arthritis; Therapeutics; Thrombomodulin

Indexed keywords

ANTIRHEUMATIC AGENT; C REACTIVE PROTEIN; CELL MARKER; DICLOFENAC; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HEMOGLOBIN; HYDROXYCHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; SALAZOSULFAPYRIDINE; THROMBOMODULIN;

ADULT; ARTHROPATHY; ARTICLE; CELL DAMAGE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DRUG RESPONSE; EDEMA; ENDOTHELIUM CELL; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; LABORATORY TEST; MALE; MEDICAL ASSESSMENT; MEDICAL PARAMETERS; MORNING STIFFNESS; PATIENT MONITORING; PHYSICIAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SIDE EFFECT; TREATMENT OUTCOME; VOLUNTEER;

ADULT; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; DRUG THERAPY, COMBINATION; E-SELECTIN; FEMALE; HEALTH STATUS; HUMANS; HYDROXYCHLOROQUINE; MALE; METHOTREXATE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SULFASALAZINE; THROMBOMODULIN; TREATMENT OUTCOME;

EID: 6344232096     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-004-0915-6     Document Type: Article

References (31)

1. Turesson C, Jacobsson L, Bergstrom U (1999) Extra-articular rheumatoid arthritis: prevalence and mortality. Rheumatology (Oxford) 38:668-674
2. Ebnet K, Vestweber D (1999) Molecular mechanisms that control leukocyte extravasations: the selectins and the chemokines. Histochem Cell Biol 112:1-23
3. Newman W, Beall LD, Carson CW et al. (1993) Soluble E-selectin is found in supernatants or activated endothelial cells and is elevated in the serum of patients with septic shock. J Immunol 150:644-654
4. Gearing AJ, Newman W (1993) Circulating adhesion molecules in disease. Immunol Today 14:506-512
5. Carson CW, Beall LD, Hunder GG, Johnson CM, Newman W (1994) Soluble E-selectin is increased in inflammatory synovial fluid. J Rheumatol 21:605-611
6. Voskuyl AE, Martin S, Melchers L, Zwinderman AH, Weichselbraun I, Breedveld FC (1995) Levels of circulating intercellular adhesion molecule-1 and -3 but not circulating endothelial leukocyte adhesion molecule are increased in patients with rheumatoid vasculitis. Br J Rheumatol 34: 311-315
7. Blann AD, Herrick A, Jayson MI (1995) Altered levels of soluble adhesion molecules in rheumatoid arthritis, vasculitis and systemic sclerosis. Br J Rheumatol 34:814-819
8. Koch AE, Turkiewicz W, Harlow LA, Pope RM (1993) Soluble E selectin in arthritis. Clin Immunol Immunopathol 69:29-35
9. Littler AJ, Buckley CD, Worthsworth P, Collins I, Martinson J, Simmons DL (1997) A distinct profile a six soluble adhesion molecules (ICAM-1, ICAM-3 VCAM-1, E-selectin, L-selectin and P-selectin) in rheumatoid arthritis. Br J Rheumatol 36:164-169
10. Salih AM, Nixon NB, Dawes PT, Mattey DL (1999) Soluble adhesion molecules and anti-endothelial cell antibodies in patients with rheumatoid arthritis complicated with peripheral neuropathy. J Rheumatol 26:551-555
11. Kuuliala A, Eberhardt K, Takala A, Kautiainen H, Repo H, Leirisalo-repo M (2002) Circulating soluble E-selectin in early rheumatoid arthritis: a prospective five year study. Ann Rheum Dis 61:242-246
12. Esmon CT (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 264:4743-4746
13. Takano S, Kimura S, Ohdama S, Aoki N (1990) Plasma thrombomodulin in health and diseases. Blood 76:2024-2029
14. Takahashi H, Ito S, Hanano M et al. (1992) Circulating thrombomodulin as a novel endothelial cell marker. Comparison of its behavior with von willebrand factor and tissue-type plasminogen activator. AM J Hematol 41:32-39
15. Ohdama S, Takano S, Miyake S, Kubota T, Sato K, Aoki N (1994) Plasma thrombomodulin as a marker of vascular injuries in collagen vascular diseases. Am J Clin Pathol 101:109-113
16. Arnett FC, Edworthy SM, Bloch DA et al. (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. 31:315-324
17. Firestein G (2001) Etiology and pathogenesis rheumatoid arthritis. In: Ruddy S, Harris ED, Sledge CB (eds) Kelly's textbook of rheumatology, 6th edn. Philadelphia, WB Saunders,pp 921-966
18. Mojcik CF, Shevach EM (1997) Adhesion molecules. A rheumatologic perspective. Arthritis Rheum 40:991-1004
19. Koch AE, Halloran MM, Haskell CJ, Shah MR, Polverini PJ (1995) Angiogenesis mediated by soluble forms o E-selectin and vascular cell adhesion molecule-1. Nature 376:517-519
20. To SST, Newman PM, Hyland VJ Robinson BG, Schrieber L (1996) Regulation of adhesion molecule expression by human synovial microvascular endothelial cells in vitro. Arthritis Rheum 39:467-477
21. Ferrara N (1995) Leukocyte adhesion. Missing link in angiogenesis. Nature 376:467
22. Conway EM, Nowakowski B, Steiner-mosonyi M (1992) Human neutrophils synthesize thrombomodulin that does not promote thrombin-dependent protein C activation. Blood 80:1254-1263
23. McCachren SS, Diggs J, Weinberg JB, Dittman WA (1991) Thrombomodulin expression by human blood monocytes and by human synovial tissue lining macrophages. Blood 78:3128-3132
24. Ishii H, Uchiyama H, Kazama M (1991) Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 65:618-623
25. Hanyu T, Arai K, Nakano M (1999) Urinary thrombomodulin in patients with rheumatoid arthritis: Relationship to disease subset. Clin Rheumatol 18:385-389
26. Çalgüneri M, Pay S, Çalişkaner Z et al. (1999) Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheumatol 17:699-704
27. Corkil MM, Kirkham BW, Haskard DO, Barbatis C, Gibson T, Panayi GS (1991) Gold treatment of rheumatoid arthritis decreases synovial expression of endothelial leucocyte adhesion receptor ELAM-1. J Rheumatol 18:1453-1460
28. Dolhain RJEM, Tak PP, Dijkmans BAC, de Kuiper P, Breedveld FC (1998) Methotrexate reduces inflammatory cell numbers, expression of monokines and adhesion molecules in synovial tissue of patients with rheumatoid arthritis. Br J Rheumatol 37:502-508
29. Tak PP, Taylor PC, Breedveld FC et al. (1996) Decrease in cellularity and expression of adhesion molecules by anti-tumor necrosis factor alpha monoclonal antibody treatment in patients with rheumatoid arthritis. Arthritis Rheum 39:1077-1081
30. Cunnane G, Madigan A, Murphy E, Fitzgerald O, Bresnihan B (2001) The effects of treatment with interleukin-1 receptor antagonist on the inflammed synovial membrane in rheumatoid arthritis. Rheumatology 40:62-69
31. Smith MD, Slavotinek J, Au V et al. (2001) Successful treatment of rheumatoid arthritis is associated with a reduction in synovial membrane cytokines and cell adhesion molecule expression. Rheumatology 40:965-977